ID: h-71dd2007
Hypothesis

Oligodendrocyte Precursor Cell Activation to Restore Structural Connectome Integrity

Oligodendrocyte Precursor Cell Activation to Restore Structural Connectome Integrity.
🧬 Oligodendrocyte Precursor Cell🩺 connectomics🎯 Composite 41%💱 $0.48▲15.5%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 5 support 5 oppose
⚠ Missing Evidence⚠ Thin Description Senate Quality Gates →
Mechanistic 0.50 (15%) Evidence 0.35 (15%) Novelty 0.70 (12%) Feasibility 0.65 (12%) Impact 0.40 (12%) Druggability 0.50 (10%) Safety 0.35 (8%) Competition 0.55 (6%) Data Avail. 0.35 (5%) Reproducible 0.30 (5%) KG Connect 0.50 (8%) 0.411 composite

🧪 Overview

Oligodendrocyte Precursor Cell Activation to Restore Structural Connectome Integrity

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Oligodendrocyte Precursor Cell<br/>Hypothesis Target"]
    B["Pathway Dysregulation<br/>Cited Mechanism"]
    C["Cellular Response<br/>Stress or Clearance Change"]
    D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
    E["Neurodegeneration<br/>Disease-Relevant Outcome"]
    A --> B
    B --> C
    C --> D
    D --> E
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports5 contradicts
Supports
Myelin breakdown is an early, underrecognized feature of AD pathophysiology
Supports
Hub regions connected by long-range white matter tracts that are particularly vulnerable
Supports
Clemastine promotes OPC differentiation and remyelination in cuprizone and EAE models
Supports
Siponimod (Mayzent) FDA-approved for secondary progressive MS
Supports
Network-level changes include reduced white matter integrity measurable by diffusion MRI
Contradicts
Myelin changes in AD may be secondary to axonal degeneration - primary vs secondary unresolved
Contradicts
White matter hyperintensities correlate with vascular pathology, not primary OPC dysfunction
Contradicts
Clemastine not advanced to AD clinical trials - off-target antihistamine effects
Contradicts
Siponimod failed in secondary progressive MS - S1P modulation insufficient for established myelin pathology
Contradicts
Aged human OPCs have substantially reduced differentiation capacity vs young animals
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — OLIGODENDROCYTE

No curated PDB or AlphaFold mapping for OLIGODENDROCYTE yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for Oligodendrocyte Precursor Cell →

No DepMap CRISPR Chronos data found for Oligodendrocyte Precursor Cell.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.7%
Volatility
Low
0.0168
Events (7d)
2
Price History
▲15.5%

💾 Resource Usage

LLM Tokens
47,826
$0.1435
Total Cost
$0.1435

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF aged (18-month) APP/PS1 Alzheimer's disease model mice receive voluntary wheel running (access 24h/day for 12 weeks) to endogenously activate OPCs, THEN stereological OPC counts in subcortical whitIncreased PDGFRα+ OPC density (criterion: >800 cells/mm² in corpus callosum) and restored structural connectome topology with normalized small-worldness index (— no observation —pending0.45
IF adult mice with cuprizone-induced demyelination receive daily intraperitoneal clemastine (10 mg/kg) for 4 weeks to pharmacologically activate OPCs, THEN quantitative measures of corpus callosum myeRemyelination of demyelinated axons with g-ratio normalization (approaching 0.7-0.8 range) and restoration of DTI FA values to ≥90% of baseline pre-demyelinatio— no observation —pending0.55
🔮 Falsifiable Predictions (2)
pendingconf 55%
IF adult mice with cuprizone-induced demyelination receive daily intraperitoneal clemastine (10 mg/kg) for 4 weeks to pharmacologically activate OPCs, THEN quantitative measures of corpus callosum myelination (g-ratio from electron microscopy) will decrease by ≥15% and diffusion tensor imaging fract
Predicted outcome: Remyelination of demyelinated axons with g-ratio normalization (approaching 0.7-0.8 range) and restoration of DTI FA values to ≥90% of baseline pre-de
Falsification: No significant change in g-ratio (remains >0.85) or FA values (<10% increase) in clemastine-treated animals compared to vehicle controls; or equivalent improvement observed in vehicle-only controls, i
pendingconf 45%
IF aged (18-month) APP/PS1 Alzheimer's disease model mice receive voluntary wheel running (access 24h/day for 12 weeks) to endogenously activate OPCs, THEN stereological OPC counts in subcortical white matter will increase by ≥40% and graph-theory structural connectivity metrics from ex vivo diffusi
Predicted outcome: Increased PDGFRα+ OPC density (criterion: >800 cells/mm² in corpus callosum) and restored structural connectome topology with normalized small-worldne
Falsification: OPC density increase <20% and no significant change in graph-theory connectivity metrics (local efficiency remains <0.3) in running vs. control groups; or OPC activation without accompanying structura
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.